Medicamen Biotech posts Rs. 3.64 Cr consolidated PAT in Q4FY21
The company has posted net profit of Rs.12.12 crores for the 12 months period ended March 31, 2021
The company has posted net profit of Rs.12.12 crores for the 12 months period ended March 31, 2021
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
Subscribe To Our Newsletter & Stay Updated